EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

KIF18B Modulates SKP2 Ubiquitination to Promote Aerobic Glycolysis and Osteosarcoma Progression

Haonan Liu, Xin Guo, Chaoxiang Lu, Daifeng Lu

International Journal of Molecular Sciences · 02.04.2026 · 27 (7) · 3235

DOI: 10.3390/ijms27073235 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 02.04.2026. Verfasst von Haonan Liu und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Clinical Medicine, Harbin Medical University, 157 Health Care Road, Nangang District, Harbin 150023, China. Hauptthemen laut MEDLINE: Osteosarcoma, S-Phase Kinase-Associated Proteins, Ubiquitination, Kinesins. Die Arbeit nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Special Scientific Research Fund Project of The Fourth Affiliated Hospital of Harbin Medical University, the Innovative Talent Program of The Fourth Affiliated Hospital of Harbin Medical University, the Heilongjiang Medical Development Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osteosarcoma (OS) is an aggressive bone malignancy with poor prognosis, characterized by high metastasis rates. Kinesin family member 18B (KIF18B), a key protein in cell division and mitosis, has emerged as a potential diagnostic and therapeutic target in various cancers, including OS. This study investigates the role of KIF18B in OS progression and its underlying mechanisms. We found that KIF18B expression is significantly upregulated in OS tissues and correlates with lymph node metastasis (N-stage) and clinical stage. Knockdown of KIF18B inhibited OS cell migration, invasion, proliferation, and tumorigenesis. Mechanistically, KIF18B promotes OS survival through the ubiquitin–proteasome system (UPS) by regulating Skp2 protein degradation. KIF18B knockdown accelerated Skp2 ubiquitination, leading to reduced Skp2 levels and inhibited OS cell viability and glycolytic metabolism. Overexpression of KIF18B enhanced OS cell viability and glycolysis in an Skp2-dependent manner. These findings suggest that the KIF18B-Skp2 axis plays a critical role in the metabolic reprogramming of OS cells and serves as a novel prognostic biomarker and therapeutic target in OS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteosarcomaS-Phase Kinase-Associated ProteinsUbiquitinationKinesinsBone NeoplasmsGlycolysisHumansCell Line, TumorAnimalsCell ProliferationCell MovementGene Expression Regulation, NeoplasticDisease ProgressionFemaleMaleMice

Stichwörter der Autor:innen

KIF18BSkp2glycolysisosteosarcomaubiquitination

Substanzen

S-Phase Kinase-Associated ProteinsSKP2 protein, humanKinesinsKIF18B protein, human

Autor:innen und Institutionen

  • School of Clinical Medicine, Harbin Medical University, 157 Health Care Road, Nangang District, Harbin 150023, China.

Förderung

  • the Special Scientific Research Fund Project of The Fourth Affiliated Hospital of Harbin Medical University
  • the Innovative Talent Program of The Fourth Affiliated Hospital of Harbin Medical University
  • the Heilongjiang Medical Development Foundation
  • the Heilongjiang Provincial Health Commission Science and Technology Program

Zitieren

APA

Liu, H., Guo, X., Lu, C., & Lu, D. (2026). KIF18B Modulates SKP2 Ubiquitination to Promote Aerobic Glycolysis and Osteosarcoma Progression. International Journal of Molecular Sciences, 27(7), 3235. https://doi.org/10.3390/ijms27073235

Vancouver

Liu H, Guo X, Lu C, Lu D. KIF18B Modulates SKP2 Ubiquitination to Promote Aerobic Glycolysis and Osteosarcoma Progression. International Journal of Molecular Sciences. 2026;27(7):3235. doi:10.3390/ijms27073235

BibTeX
@article{Liu2026,
  author = {Liu, Haonan and Guo, Xin and Lu, Chaoxiang and Lu, Daifeng},
  title = {KIF18B Modulates SKP2 Ubiquitination to Promote Aerobic Glycolysis and Osteosarcoma Progression},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {7},
  pages = {3235},
  doi = {10.3390/ijms27073235}
}
Kostenlos starten →